About us Newsletter News Widget Media Inquiries

Media Inquiries

Your experience will be better in the app

Install

Sign Up | Log In

Menu

Contact Us Terms of Service Support Privacy Policy Archive

© 2024 Otherweb

Follow

Featured Podcast EpisodesThe Other Web

Alex Fink

Zuckerman vs Zuckerberg

July 14, 2024

Ethan Zuckerman is a professor at the University of Massachusetts Amherst and a scholar of digital media. He and his team work to understand the contemporary digital world and build social media systems that are focused on communities, not on profits. Ethan is currently suing Meta (i.e. Facebook) in a landmark case that might (and likely should) change our interpretation of section 230. Please tune in to hear the details of the case and the various ways it could change the social media landscape. It's fascinating!

Prof. Jeff Jarvis - Rewriting Media's Business Model (Yet Again)

May 24, 2024

Jeff Jarvis is a journalism professor at the City College in New York (CUNY), the author of six books, and the cohost of the successful podcast "This week in Google and AI". Jeff spent many years teaching entrepreneurial journalism - and God knows journalism could use some entrepreneurial spirit, right about now. Please check out Jeff's books, The Gutenberg Parenthesis and Magazine, both from Bloomsbury (discount codes here: gutenbergparenthesis.com).

Donald Robertson - Where Philosophy Meets Psychology

June 22, 2024

Our guest today is Donald Robertson - Donald is a cognitive-behavioral psychotherapist and author of several books, including How to Think Like a Roman Emperor and, more recently, Marcus Aurelius: The Stoic Emperor. He is one of the founders of the Modern Stoicism nonprofit organization and the founder and president of the Plato's Academy Centre in Athens, Greece. He was born in Scotland but now lives in Montreal, Canada. His upcoming book, How to Think Like Socrates, will be released later this year, and can be preordered on Amazon, Barnes and Noble, or anywhere else books are generally sold.

Rick Edmonds - Analyzing the Financial Decline of Legacy Media

July 8, 2024

Rick Edmonds is the media business analyst for the Poynter Institute, a school and study center for working journalists. He has been doing research and writing for 25 years on the financial decline of legacy media, newspapers particularly, and the rise of new media alternatives. His reporting and commentary appear regularly on the Poynter Online site. He has spoken to conference groups in the U.S.A. and in Paris, Norway, Madrid, Vienna and Chile.

Jonathan Green - How To Make ChatGPT and Other Tools Useful (Right Now)

July 5, 2024

Welcome to the Otherweb. Our guest today is Jonathan Green - a bestselling author of hundreds of books, a celebrity ghostwriter, and an expert in using artificial intelligence tools to their utmost capacity. This is the best conversation I've had on the practical implications of ChatGPT and how regular people can augment their own capabilities by using these tools as a shortcut.

1h 4m

📌 Trump’s Picks, Rules ‘Rushed,’ More

Angela Palmer

•

TOP STORY

TOP STORY

Trump picks campaigners for key positions

WORLD

WORLD

Approval of ‘climate credit’ rules was rushed

POLITICS

POLITICS

Ruben Gallego wins Arizona US Senate race

All Stories

Summary

Article Metadata

Experimental HIV Treatment Sustains Function

This is a news story, published by Live Science, that relates primarily to Michael Schubert news.

Michael Schubert news

For more Michael Schubert news, you can click here:

more Michael Schubert news

biology news

For more biology news, you can click here:

more biology news

Live Science news

For more news from Live Science, you can click here:

more news from Live Science

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best science news, business news, entertainment news, and much more. If you like biology news, you might also like this article about

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest antiretroviral therapy news, antiretroviral drugs news, biology news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

experimental HIV treatment

Live Science

Live Science

•

Single-shot HIV treatment suppresses virus 10,000-fold for months, animal study finds

Live Science

Summary

Nutrition label

78% Informative

Researchers have developed an experimental HIV treatment that sustains itself in the body.

The new treatment has been tested in monkeys, not people, but in the monkeys it suppressed HIV for at least seven months .

About 40 million people worldwide are living with HIV, but only about three-quarters are currently receiving antiretroviral therapy.

Michael Schubert is a veteran science and medicine communicator.

He specializes in the study of the very small — from genes that make our bodies work to the chemicals that could support life on other planets.

When he's not writing or editing, he's a dog-walker and ball-thrower extraordinaire.

VR Score

85

Informative language

87

Neutral language

56

Article tone

informal

Language

English

Language complexity

58

Offensive language

possibly offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

long-living

External references

11

https://www.unaids.org/en/resources/fact-sheet https://evolution.berkeley.edu/the-relevance-of-evolution/medicine/hiv-the-ultimate-evolver/https://news.ohsu.edu/2024/08/08/study-single-experimental-shot-reduces-hiv-levels-1-000-fold https://hivinfo.nih.gov/understanding-hiv/fact-sheets/fda-approved-hiv-medicines#:~:text=People%20on%20ART%20take%20a,two%20different%20HIV%20drug%20classes.https://www.cdc.gov/hiv/risk/art/index.html https://www.iq-idm.com/adrian-wildfire https://www.fda.gov/drugs/hiv-treatment/hiv-treatment-information-adults https://retrovirology.biomedcentral.com/articles/10.1186/s12977-018-0395-4#Sec12 https://www.aidsmap.com/about-hiv/what-do-we-know-about-injectable-hiv-medication#toc-how-frequent-are-the-injections https://www.science.org/doi/10.1126/science.adn5866 https://gladstone.org/people/leor-weinberger

Source diversity

11

www.unaids.org evolution.berkeley.edu news.ohsu.edu hivinfo.nih.gov www.cdc.gov www.iq-idm.com www.fda.gov retrovirology.biomedcentral.com www.aidsmap.com www.science.org gladstone.org

Affiliate links

1

https://www.awin1.com/awclick.php?awinmid=2961&awinaffid=103504&clickref=livescience-us-1039073830878148176&p=https%3A%2F%2Fwww.magazinesdirect.com%2Faz-magazines%2F6936539%2Fhow-it-works-magazine-subscription.thtml

Read full article